Auspex Pharmaceuticals News
Most Popular Auspex Pharmaceuticals Story
Emerging Drug Developer: Auspex Pharmaceuticals
Promise of deuterium lures biotech vet to Auspex When Ajit Gill retired from Nektar Therapeutics after a 14-year stint, he was ready for something new. Nektar had swelled into a developer with a big Read more...
Latest Headlines
- May 19, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
